{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:36:55Z","timestamp":1785346615845,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12817-6","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:15:01Z","timestamp":1770657301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lucy X.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Po-Yu","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin K.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Werbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitipong","family":"Permpalung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"12817_CR1","unstructured":"WHO Coronavirus (COVID-19.) Dashboard https:\/\/data.who.int\/dashboards\/covid19\/."},{"issue":"7","key":"12817_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3201\/eid2907.221771","volume":"29","author":"JAW Gold","year":"2023","unstructured":"Gold JAW, Adjei S, Gundlapalli AV, Huang YA, Chiller T, Benedict K, Toda M. Increased hospitalizations involving fungal infections during COVID-19 Pandemic, united States, January 2020-December 2021. Emerg Infect Dis. 2023;29(7):1433\u20137.","journal-title":"Emerg Infect Dis"},{"key":"12817_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","volume":"113","author":"WH Chong","year":"2021","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115\u201329.","journal-title":"J Hosp Infect"},{"issue":"10","key":"12817_CR4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jiph.2023.07.005","volume":"16","author":"AS Suleiman","year":"2023","unstructured":"Suleiman AS, Islam MA, Akter MS, Amin MR, Werkneh AA, Bhattacharya P. A meta-meta-analysis of co-infection, secondary infections, and antimicrobial resistance in COVID-19 patients. J Infect Public Health. 2023;16(10):1562\u201390.","journal-title":"J Infect Public Health"},{"key":"12817_CR5","doi-asserted-by":"publisher","first-page":"888452","DOI":"10.3389\/fmicb.2022.888452","volume":"13","author":"SS Seyedjavadi","year":"2022","unstructured":"Seyedjavadi SS, Bagheri P, Nasiri MJ, Razzaghi-Abyaneh M, Goudarzi M. Fungal infection in Co-infected patients with COVID-19: an overview of case Reports\/Case series and systematic review. Front Microbiol. 2022;13:888452.","journal-title":"Front Microbiol"},{"key":"12817_CR6","doi-asserted-by":"crossref","unstructured":"Gioia F, Walti LN, Orchanian-Cheff A, Husain S. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Lancet Respir Med. 2024.","DOI":"10.1016\/S2213-2600(23)00408-3"},{"issue":"7","key":"12817_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/TP.0000000000004947","volume":"108","author":"N Permpalung","year":"2024","unstructured":"Permpalung N, Chiang TP, Manothummetha K, Ostrander D, Datta K, Segev DL, Durand CM, Mostafa HH, Zhang SX, Massie AB, et al. Invasive fungal infections in inpatient solid organ transplant recipients with COVID-19: A multicenter retrospective cohort. Transplantation. 2024;108(7):1613\u201322.","journal-title":"Transplantation"},{"issue":"7","key":"12817_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.healun.2023.02.005","volume":"42","author":"N Permpalung","year":"2023","unstructured":"Permpalung N, Liang T, Gopinath S, Bazemore K, Mathew J, Ostrander D, Durand CM, Shoham S, Zhang SX, Marr KA, et al. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year. J Heart Lung Transpl. 2023;42(7):953\u201363.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"12817_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ajt.2024.10.004","volume":"25","author":"KD Volesky-Avellaneda","year":"2025","unstructured":"Volesky-Avellaneda KD, Pfeiffer RM, Shiels MS, Castenson D, Miller JM, Wang JH, Yu KJ, Avellaneda F, Massie AB, Segev DL, et al. The burden of COVID-19 mortality among solid organ transplant recipients in the united States. Am J Transpl. 2025;25(3):602\u201310.","journal-title":"Am J Transpl"},{"issue":"8","key":"12817_CR10","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/ajt.17036","volume":"22","author":"AB Massie","year":"2022","unstructured":"Massie AB, Werbel WA, Avery RK, Po-Yu Chiang T, Snyder JJ, Segev DL. Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era. Am J Transpl. 2022;22(8):2077\u201382.","journal-title":"Am J Transpl"},{"key":"12817_CR11","doi-asserted-by":"crossref","unstructured":"Lee WE, Woo Park S, Weinberger DM, Olson D, Simonsen L, Grenfell BT, Viboud C. Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022. Elife. 2023;12.","DOI":"10.7554\/eLife.77562"},{"issue":"3","key":"12817_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/eurpub\/ckab047","volume":"31","author":"CM Roy","year":"2021","unstructured":"Roy CM, Bollman EB, Carson LM, Northrop AJ, Jackson EF, Moresky RT. Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: a scoping review. Eur J Public Health. 2021;31(3):634\u201340.","journal-title":"Eur J Public Health"},{"issue":"3","key":"12817_CR13","doi-asserted-by":"publisher","first-page":"e045343","DOI":"10.1136\/bmjopen-2020-045343","volume":"11","author":"R Moynihan","year":"2021","unstructured":"Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, Jones M, Kitchener E, Fox M, Johansson M, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343.","journal-title":"BMJ Open"},{"issue":"1","key":"12817_CR14","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1093\/cid\/ciac055","volume":"75","author":"AC Perofsky","year":"2022","unstructured":"Perofsky AC, Tempia S, Bingham J, Maslo C, Toubkin M, Laubscher A, Walaza S, Pulliam JRC, Viboud C, Cohen C. Direct and indirect effects of the coronavirus disease 2019 pandemic on private healthcare utilization in South Africa, March 2020-September 2021. Clin Infect Dis. 2022;75(1):e1000\u201310.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"12817_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ajt.2023.10.017","volume":"24","author":"E Leye","year":"2024","unstructured":"Leye E, Delory T, El Karoui K, Espagnacq M, Khlat M, Le Coeur S, Lapidus N, Hejblum G. Group C-Hw: direct and indirect impact of the COVID-19 pandemic on the survival of kidney transplant recipients: A National observational study in France. Am J Transpl. 2024;24(3):479\u201390.","journal-title":"Am J Transpl"},{"key":"12817_CR16","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"2","key":"12817_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"issue":"1","key":"12817_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64(1):87\u201391.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"12817_CR19","doi-asserted-by":"publisher","first-page":"e13528","DOI":"10.1111\/ctr.13528","volume":"33","author":"HH Hirsch","year":"2019","unstructured":"Hirsch HH, Randhawa PS. Practice astidco: BK polyomavirus in solid organ transplantation-Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33(9):e13528.","journal-title":"Clin Transpl"},{"issue":"5","key":"12817_CR20","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/ajt.16383","volume":"21","author":"M Mombelli","year":"2021","unstructured":"Mombelli M, Lang BM, Neofytos D, Aubert JD, Benden C, Berger C, Boggian K, Egli A, Soccal PM, Kaiser L, et al. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. Am J Transpl. 2021;21(5):1789\u2013800.","journal-title":"Am J Transpl"},{"issue":"3","key":"12817_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285\u201392.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12817_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12817_CR23","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O\u2019Grady NP, Bartlett JG, Carratala J, et al. Management of adults with Hospital-acquired and Ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12817_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12817_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12561-013-9085-x","volume":"6","author":"Y Li","year":"2014","unstructured":"Li Y, Schaubel DE, He K. Matching methods for obtaining survival functions to estimate the effect of a time-dependent treatment. Stat Biosci. 2014;6(1):105\u201326.","journal-title":"Stat Biosci"},{"issue":"1","key":"12817_CR26","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1038\/s41598-020-60973-9","volume":"10","author":"A Winter","year":"2020","unstructured":"Winter A, Feray C, Antoine C, Azoulay D, Daures JP, Landais P. Matching graft quality to recipient\u2019s disease severity based on the survival benefit in liver transplantation. Sci Rep. 2020;10(1):4111.","journal-title":"Sci Rep"},{"issue":"3","key":"12817_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1541-0420.2006.00527.x","volume":"62","author":"DE Schaubel","year":"2006","unstructured":"Schaubel DE, Wolfe RA, Port FK. A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies. Biometrics. 2006;62(3):910\u20137.","journal-title":"Biometrics"},{"issue":"11","key":"12817_CR28","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1111\/ajt.16185","volume":"20","author":"P Cravedi","year":"2020","unstructured":"Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, P\u00e9rez-S\u00e1ez MJ, Redondo-Pach\u00f3n MD, Murphy B, Florman S, Cyrino LG, et al. COVID-19 and kidney transplantation: results from the TANGO international transplant consortium. Am J Transpl. 2020;20(11):3140\u20138.","journal-title":"Am J Transpl"},{"issue":"12","key":"12817_CR29","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1111\/ajt.16742","volume":"21","author":"D Kremer","year":"2021","unstructured":"Kremer D, Pieters TT, Verhaar MC, Berger SP, Bakker SJL, van Zuilen AD, Joles JA, Vernooij RWM, van Balkom BWM. A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: lessons to be learned. Am J Transpl. 2021;21(12):3936\u201345.","journal-title":"Am J Transpl"},{"issue":"5","key":"12817_CR30","doi-asserted-by":"publisher","first-page":"e14333","DOI":"10.1111\/tid.14333","volume":"26","author":"SB Lee","year":"2024","unstructured":"Lee SB, Dai R, French E, Anzalone JA, Olex AL, Ge J, Schissel M, Agarwal G, Vinson A, Madhira V, et al. Risk factors for severe outcomes of coronavirus disease 2019 through the waves of the pandemic: comparing patients with and without solid organ transplantation. Transpl Infect Dis. 2024;26(5):e14333.","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"12817_CR31","doi-asserted-by":"publisher","first-page":"sfaf030","DOI":"10.1093\/ckj\/sfaf030","volume":"18","author":"A Nowak","year":"2025","unstructured":"Nowak A, Caldinelli A, Segelmark M, Rydell H, Artborg A, Bellocco R, Stendahl M, Lindholm B, Wijkstrom J, Evans M. COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic. Clin Kidney J. 2025;18(3):sfaf030.","journal-title":"Clin Kidney J"},{"issue":"8","key":"12817_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S2213-2600(21)00095-3","volume":"9","author":"P Aveyard","year":"2021","unstructured":"Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, Coupland CAC, Tan PS, Clift AK, Harrison D, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909\u201323.","journal-title":"Lancet Respir Med"},{"key":"12817_CR33","unstructured":"COVID data tracker. https:\/\/covid.cdc.gov\/covid-data-tracker."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12817-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:30:02Z","timestamp":1773397802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12817"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12817-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed by the Johns Hopkins University institutional review board and determined to be exempt from humans subject research with a waiver of consent (IRB00212246). As such, no informed consent was required. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JX is currently employed by CareDx. SXZ is partially supported by funding from IMMY Diagnostics, Vela Diagnostics, Applied BioCode, T2 Biosystems, Pearl Diagnostics, and Scanogen. JWB was a prior consultant for Pfizer. SS receives funding from F2G, Cidara, Ansun, and Zeteo; consults for Celtrion, Adagio, Immunome, Scynexis, Karius, and Pfizer; and has stock options with Immunome. SS also served on the Board of Governors of the American College of Physicians. CMD received payments from Gilead for grant reviewing and conducts research studies with drug donated by Gilead. WAW has received consulting and\/or speaking fees from AstraZeneca and advisory board fees from AstraZeneca and Novavax. KAM discloses employment and equity in Elion Therapeutics and equity and royalty income from Pearl Diagnostics. RKA receives study funding from Aicuris, Astra-Zeneca, Merck, Takeda, and United Therapeutics. NP consults for Shionogi Inc, Pulmocide, Ltd, ClearView HealthCare Partners, and Alcimed, and receives study grant support from CareDx, IMMY Diagnostics, and Merck.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}